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Abstract
Background: Mobile health (mHealth) has been described as a health enabling tool that impacts positively on
the health system in terms of improved access, quality and cost of health care. The proposed systematic
review will examine the impact of mHealth on health systems by assessing access, quality and cost of health
care as indicators.
Methods: The systematic review will include literature from various sources including published and
unpublished/grey literature. The databases to be searched include: PubMed, Cochrane Library, Google Scholar,
NHS Health Technology Assessment Database and Web of Science. The reference lists of studies will be
screened and conference proceedings searched for additional eligible reports. Literature to be included will
have mHealth as the primary intervention. Two authors will independently screen the search output, select
studies and extract data; discrepancies will be resolved by consensus and discussion with the assistance of
the third author.
Discussion: The systematic review will inform policy makers, investors, health professionals, technologists and
engineers about the impact of mHealth in strengthening the health system. In particular, it will focus on
three metrics to determine whether mHealth strengthens the health system, namely quality of, access to and
cost of health care services.
Systematic review registration: PROSPERO CRD42015026070
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Background
A health system is defined as an organization that encom-
passes all institutions, people and actions whose core
interest is to promote, restore or maintain health [1]. It is
further characterized according to its main purposes of fi-
nancing, provision of inputs and service delivery/coverage.
The key role players include government and consumers,
and the outcomes include health, fairness in financing and
responsiveness [2].
Mobile health or mHealth refers to the use of wireless
communication devices to support public health and
clinical practice [3]. It is considered a health enabling
tool that impacts positively on the health system in
terms of improved access and quality of health care and
reduction in the cost of health services. Health enabling
tools include health information systems, health promo-
tion programmes, decision support systems and pre-
ventative programmes (e.g. vaccination programmes).
The mobile devices or technologies used in mHealth in-
clude handsets or mobile devices, personal digital assis-
tants (PDA) and mobile phones with PDA functions,
smartphones, tablets also known as ultra-portable com-
puters and portable media players [4].
As technology is evolving so are the capabilities of mo-
bile phones; this has led to the widespread use of mobile
phones and in turn the application of mobile health [5–7].
Globally, the number of mobile subscriptions is growing
exponentially and in some countries exceeds the popula-
tion size [8, 9]. The literature suggests that there is a lack
* Correspondence: jill.fortuinabrahams@uct.ac.za
1Division of Biomedical Engineering, Department of Human Biology, Faculty
of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape
Town 7925, South Africa
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fortuin et al. Systematic Reviews  (2016) 5:200 
DOI 10.1186/s13643-016-0387-1
of rigorous scientific evidence on the benefits of mHealth
especially in terms of randomized controlled trial studies
[4]. Research studies are often inconclusive due to small
sample size or short study duration [10, 11]. Furthermore,
there is an absence of evidence demonstrating the ability
of mHealth to strengthen the health system [12].
The purpose of this systematic review is to ascertain
whether mHealth has an impact on the health system,
particularly on quality, access and cost. These interre-
lated factors are some of the biggest challenges in deliv-
ering health care globally [13] and comprise the “iron
triangle” of health care [14]. To advance the perform-
ance of the health system, the components of the tri-
angle need to be in equilibrium [15].
Rationale
The systematic review will reveal whether mHealth solu-
tions have an impact on improving access to health care,
quality of health care and/or reducing the cost of deliver-
ing health care. It will also describe the implementation of
relevant mHealth solutions, the target audiences and the
outcomes. The data collected will be mapped to highlight
the strengths and weakness of mHealth in terms of its im-
pact on the health system. This will create opportunities
for further research and development that results in new
processes, products, publications and/or policies.
This systematic review varies from similar studies as it
examines three metrics for evaluating the impact of
mhealth on the health system, namely access, quality
and cost. Furthermore, the study focusses on developing
regions.
Research question
The aim of this review is to give an accurate account of
how mHealth impacts on the health system. This impact
would be described in terms of one or more of three
metrics. The research question to be addressed is: Does
mHealth improve the health system in terms of access,
quality and cost compared to conventional health
services?
The participants in all studies assessed are human sub-
jects. The intervention is mHealth, and the comparator
is conventional health care methods. The outcome iden-
tifies if mHealth impacts the health system by assessing
access, quality and/or cost of healthcare.
Methods and design
This systematic protocol has been registered with
PROSPERO, the International Database of Prospect-
ively Register of Systematic Reviews [16]. The regis-
tration number is CRD42015026070. The authors
acknowledge that it adheres to the PRISMA-P 2015
checklist as a condition of submission of systematic
review protocols (see Additional file 1) [17].
Eligibility criteria
Study design
The type of research to be included in this review fo-
cusses on quantitative studies. The study design includes
randomized and non-randomized studies. The types of
non-randomized studies includes case-control, cohort
and cross-sectional studies in which mHealth is the pri-
mary intervention used.
Study participants
All studies that describe mHealth targeted at individuals
or groups and aimed at that improving access to, quality
of and cost of health care services will be eligible for in-
clusion. Study participants to be included will represent
all ages, gender, ethnicity, employment status, occupa-
tion and roles in the reviewed study (i.e. patients and
health professionals).
Type of intervention
mHealth interventions to be included in the study should
aim to strengthen the health system by improving access
to, quality of and reducing the cost of health care.
The technology used for mHealth would include mo-
bile devices which have cellular communication capabil-
ities that allow for wireless interaction. The following
mobile devices or mobile electronic devices, having wire-
less and/or 3G capabilities, will be considered as inter-
ventions for inclusion in the study: mobile phones
(including android, smart and feature phones), PDA and
PDA phones, tablets, ultra-portable computers and
smart books [4, 18].
mHealth functions consist of voice calling, voice over
internet protocol (VOIP), short message service (SMS)
or text messaging, multimedia message service (MMS)
and the Internet [19]. The applications that are used
most often in mobile health are (1) client education and
behaviour change, (2) sensors and point of care devices,
(3) registries and vital event tracking, (4) data collection
and reporting, (5) electronic health records, (6) elec-
tronic decision support, (7) provider-provider communi-
cation, (8) provider work planning and scheduling, (9)
provider training and education, (10) human resource
management, (11) supply chain management and (12) fi-
nancial transactions and incentives [20].
Outcomes
The primary outcome in this review would be to deter-
mine whether mHealth strengthens the health system. To
measure the improvement, this study will extract data of
concerning at least one of the three metrics with mHealth
as the primary intervention. In this study, access would be
defined as the prospect to acquire healthcare through the
availability and supply of services [21]. Quality would refer
to the delivery of healthcare which is safe, effective, timely
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and equitable. Most importantly, quality refers to services
having a positive health outcome [22]. The cost of health-
care addresses whether there is a cost benefit, cost saving
and cost effectiveness. The questions that will be used in
answering the metrics include:
Does mHealth allow for patients and/or health profes-
sionals to access health services? The types of measure-
ment that we would expect to obtain in the literature
would refer to increase in patient attendance at health
facilities or for services. Other measurements include
patient adherence or decreases in the number of patients
that are not compliant.
When using mHealth, has the quality of service been
maintained or has it improved? The type of answer
would include whether waiting times have been reduced,
or whether the time required to access specialist care
has improved because of mHealth.
What are the cost implications when using mHealth?
The data to be extracted would contain information
about whether mHealth has resulted in a cost benefit or
cost saving.
Study setting
The setting of the study will be limited to developing
countries as defined by the United Nations Millennium
Development Goals (MDG) regions. The regions include
Caucasus and Central Asia, eastern Asia, Latin America
and the Caribbean, northern Africa, Oceania, South-
eastern Asia, southern Asia, Sub-Saharan Africa and
western Asia [23].
Search strategy
We will identify relevant studies within the period 1 Janu-
ary 1973 through 31 December 2016 with no language re-
strictions. The start date has been selected as 1 January
1973, as this is the approximate time when Motorola in-
troduced the first cell phone [24]. The time period is
broad to ensure comprehensive coverage of the literature.
The databases to be searched include: PubMed
(NLM); Scopus; PsycINFO, EMBASE; Cochrane Library
(Wiley) (including Cochrane Central Register of Con-
trolled Trials (CENTRAL), Cochrane Database of Sys-
tematic Reviews, Cochrane Methodology Register, NHS
Health Technology Assessment Database, ISI Web of
Science (Science Citation Index), POPLINE, Global
Health (Ovid), Pan-African and WHO-International
Clinical Trials Registry Platform (ICTRP)).
The studies to be included will be selected using pre-
defined search terms adapted for the databases to be
used. The terms comprise both free text word and med-
ical subject heading (MeSH). The terms will describe
mHealth, health system, access, quality and cost. Table 1
depicts the search strategy to be used for PubMed, and
these will be adapted as required for other databases.
The search strategy was developed in consultation
with a health sciences information specialist. The search
strategy will be tested and revised in consultation with
the information specialist prior to the final search.
Searching other sources
The reference lists of appropriate studies will be assessed.
Full text articles of the studies extracted from the refer-
ence list will be obtained and reviewed for additional in-
formation. Unpublished studies/grey literature will be
identified; this is an important component of the system-
atic review. These studies will be sourced through: con-
tacting the corresponding authors for missing information
or unpublished data and hand searching of relevant re-
ports and conference proceedings. Some of the databases
to be searched for unpublished literature include the New
York Academy of Literature, OpenGrey and the World
Health Organization Working Group on mHealth.
Study selection
Once the search strategy has been finalized and tested,
the first author will retrieve all the relevant articles from
the various databases. All the literature obtained will be
saved in Endnote reference management software for
further analysis.
The titles and abstracts of studies identified by the lit-
erature search will be screened independently by two au-
thors for eligibility. Two authors will make a final
assessment for inclusion using the full text article, and
discrepancies and disagreements will be resolved by a
third author. Clear reasons for exclusion will be docu-
mented by each reviewer.
Data extraction
A standardized form will be developed and piloted to ex-
tract data from the eligible studies. Discrepancies
amongst the two authors in the process of data extrac-
tion will be resolved through discussion. When no con-
sensus is reached, a third author will mediate. Key
information to be extracted includes:
 author/s and year of the study
 country of study setting
 type of facility/environment (e.g. diabetic clinic,
paediatric hospital, community)
 affiliation of author
 type of participant/study population/demographic
characteristics (e.g. children under 5 years attending
pre-school)
 type of mobile device used
 nature of the mHealth intervention
 type of study (i.e. study design)
 type of outcomes measured
 findings/results
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Data will be entered into Review Manager (RevMan)
software, Version 5.1. Copenhagen: The Nordic
Cochrane Centre, the Cochrane Collaboration, 2011 by
JF. The second author will verify the data entered, for
missing or incorrect data.
Assessing risk of bias
Bias will be assessed by two authors independently
using the criteria as stipulated by the International
Cochrane Collaboration. The key elements of the
criteria include randomization sequence generation,
allocation concealment, blinding of participants, com-
pleteness of outcome data, selective outcome report-
ing and other sources of bias. For each included
study, we will report our assessment of risk of bias,
i.e. low, high or unclear risk for each domain, to-
gether with a descriptive summary of the information
that influenced our judgement. Two authors will
apply the criteria, and we will discuss any discrepan-
cies and disagreement on bias, which will be resolved
in consultation with a third author.
Data analysis and synthesis
This systematic review will determine the impact of
mHealth on the health system focussing on three met-
rics, namely cost, quality and access. Despite the varying
participants, study designs, geographical location and
intervention, the most important component is to deter-
mine the impact of mHealth on the health system using
one or more of the metrics.
The result of each study will be expressed as a risk ra-
tio with its corresponding 95% confidence interval (CI)
for dichotomous data or a mean difference with its 95%
CI for continuous data. The studies will be clustered
around similar types of participants, interventions, study
designs and outcomes for an overall estimate of effect.
The data will be pooled from studies of similar interven-
tions, participants, outcomes and study designs in a
meta-analysis using the random-effects model if there is
no significant statistical heterogeneity, methodological
difference or high risk of bias. If variation between stud-
ies in the reported interventions, participants, study de-
signs and outcome measures is encountered, we will not
pool the results but summarize the findings in a narra-
tive format. Regression analysis of the interrupted time
series (ITS) studies will be conducted with time trends
before and after the interventions. The presentation of
results for the ITS study outcomes will be represented
as change in level and slope [25]. In the event, ITS stud-
ies have been incorrectly analysed by the study authors
and the data points have been provided, we will re-
analyse them using a regression analysis.
The findings will also be mapped to depict a holistic




#6 Search (((((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms])
OR wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((((quality[MeSH Terms]) OR quality assurance[MeSH Terms])
OR clinical efficacy[MeSH Terms]) OR efficacy[MeSH Terms]))) AND ((health system[MeSH Terms]) OR health services[MeSH Terms])
Filters: Publication date from 1973/01/01 to 2015/12/31; Humans
68
#5 Search (((((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms])
OR wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((health services accessibility[MeSH Terms]) OR access[MeSH
Terms]))) AND ((health system[MeSH Terms]) OR health services[MeSH Terms]) Filters: Publication date from 1973/01/01 to
2015/12/31; Humans; English
11
#4 Search (((((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms])
OR wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((((cost[MeSH Terms]) OR cost benefit[MeSH Terms]) OR cost
saving[MeSH Terms]) OR cost effectiveness[MeSH Terms]))) AND ((health system[MeSH Terms]) OR health services[MeSH Terms])
Filters: Publication date from 1973/01/01 to 2015/12/31; Humans; English
19
#3 Search (((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms]) OR
wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((((quality[MeSH Terms]) OR quality assurance[MeSH Terms])
OR clinical efficacy[MeSH Terms]) OR efficacy[MeSH Terms]) Filters: Publication date from 1973/01/01 to 2015/12/31; Humans; English
167
#2 Search (((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms]) OR
wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((health services accessibility[MeSH Terms]) OR access[MeSH
Terms]) Filters: Publication date from 1973/01/01 to 2015/12/31; Humans; English
18
#1 Search (((((((((((mhealth[All Fields]) OR telemedicine[MeSH Terms]) OR cellphone[MeSH Terms]) OR reminder system[MeSH Terms]) OR
wireless technology[MeSH Terms])OR text messaging[MeSH Terms]) OR medical informatics[MeSH Terms]) OR pda[MeSH Terms])
ORsmartphone[MeSH Terms]) OR tablet computer[MeSH Terms])) AND ((((cost[MeSH Terms]) OR cost benefit[MeSH Terms]) OR cost
saving[MeSH Terms]) OR cost effectiveness[MeSH Terms]) Filters: Publication date from 1973/01/01 to 2015/12/31; Humans; English
46
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In particular, it will highlight the benefits and challenges
in the various studies analysed according to the metrics
cost, quality and access.
Dealing with missing data
When deemed necessary, the authors of studies will be
contacted for all missing or incomplete data. Should
there be no response from the authors, the limited data
available will be included and the implications of miss-
ing/incomplete data will be discussed.
Assessment of heterogeneity
Clinical heterogeneity will be assessed by examining
types of participants, interventions and outcomes in
each study. Those studies identified as being clinically
homogenous will be pooled. Heterogeneity between
studies will be evaluated using chi-square tests and I-
squared statistics. If studies are found to be sufficiently
homogenous, in terms of study population, intervention,
geographical location and outcomes, the data will be
pooled and estimate summary effect sizes will be deter-
mined using a fixed effects model. Alternatively, a ran-
dom effects model will be used in case of heterogeneity.
Subgroup analysis
The purpose of the subgroup analysis in this study is to
determine if varying mHealth applications have an effect
on the health system and in what context this occurs.
It is expected that the geographical location, mHealth
intervention, health system structure and country in-
come of various studies will be varied. Those countries
with similar income levels as defined by the World Bank
will be grouped [26]. Participants and mHealth interven-
tions with similar characteristics will also be grouped.
The aim of the statistical analysis would be to deter-
mine whether the mHealth intervention has the same ef-
fect across varying subgroups, this is called a test of
interaction. As we are testing more than one outcome,
we are trying to explain that the mHealth intervention/
common factor would yield the same positive result re-
gardless of the characteristics such as geographical loca-
tion, type of participant or structure of the health
system. Conducting the subgroup analysis would add
credibility to the review.
Sensitivity analysis
A sensitivity analysis will be undertaken to determine
study quality in terms of risk of bias, level of participant
drop-out and statistical method (random-effect vs fixed-
effect model). In addition, the sensitivity analysis will de-
termine whether excluded studies have any impact.
Discussion
The recent proliferation of mobile communication de-
vices has fuelled an increase in mHealth services. It is
not clear whether the promise of greater access to, im-
proved quality and reduced cost of health care has been
realized. The proposed systematic review will inform fur-
ther research and innovation in terms of benefits and
shortcomings that mHealth may have in the health sys-
tem. The review will particularly focus on whether
mHealth is effective in improving access to and quality
health care services and whether costs associated with
mHealth are reduced.
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